Cited by 596Retinoids in leukemia and cellular processesPeroxisome Proliferator-Activated ReceptorsHistone Deacetylase Inhibitors Research

Retinoids, Retinoic Acid Receptors, and Cancer

Tang, Xiao-Han, Gudas, Lorraine J.·2011·Annual Review of Pathology: Mechanisms of Disease

Abstract

Retinoids (i.e., vitamin A, all-trans retinoic acid, and related signaling molecules) induce the differentiation of various types of stem cells. Nuclear retinoic acid receptors mediate most but not all of the effects of retinoids. Retinoid signaling is often compromised early in carcinogenesis, which suggests that a reduction in retinoid signaling may be required for tumor development. Retinoids interact with other signaling pathways, including estrogen signaling in breast cancer. Retinoids are used to treat cancer, in part because of their ability to induce differentiation and arrest proliferation. Delivery of retinoids to patients is challenging because of the rapid metabolism of some retinoids and because epigenetic changes can render cells retinoid resistant. Successful cancer therapy with retinoids is likely to require combination therapy with drugs that regulate the epigenome, such as DNA methyltransferase and histone deacetylase inhibitors, as well as classical chemotherapeutic agents. Thus, retinoid research benefits both cancer prevention and cancer treatment.

Integrity signals

Registry

Crossref · 10.1146/annurev-pathol-011110-130303

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Retinoic acid can enhance or decrease expression of more than 500 genes depending on the target cell type and the physiological state of the organism.

    “Retinoic acid can enhance or decrease expression of more than 500 genes depending on the target cell type and the physiological state of the organism [12,13].”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Tang, X.-H., & Gudas, L. J.
Affiliations
Weill Cornell Medicine (US)
Venue
Annual Review of Pathology: Mechanisms of Disease
Published
2011-02-28
Volume
6
Issue
1
Pages
345-364
ISSN
  • 1553-4006 (ISSN-L)
  • 1553-4014
OpenAlex
W2159159025
Cited by
596
References
7
Citations by year
2026: 17 · 2025: 37 · 2024: 27 · 2023: 31 · 2022: 44 · 2021: 46 · 2020: 29 · 2019: 44 · 2018: 31 · 2017: 48 · 2016: 44 · 2015: 53 · 2014: 40 · 2013: 38 · 2012: 48
FWCI
4.18
Type
journal article
Language
en
Open access
closed
Locations
  • Annual Review of Pathology Mechanisms of Disease (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institute for Health and Care Research
  • National Institutes of Health
  • National Cancer Institute (R01CA043796)
  • National Institute of Dental and Craniofacial Research (R01DE010389)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Retinoids in leukemia and cellular processes
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Histone Deacetylase Inhibitors Research
Keywords
retinoids, retinoic acid receptor, vitamin A, all-trans retinoic acid, retinoid signaling, carcinogenesis, stem cell differentiation, breast cancer, estrogen signaling, retinoid resistance, epigenetic modifications, hypomethylating agents, histone deacetylase inhibitors, combination therapy, cancer prevention, cancer therapy
MeSH terms
Animals, Humans, Neoplasms, Retinoids, Signal Transduction, Receptors, Retinoic Acid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review